Emmaus Life Sciences, Inc.
EMMA
$0.07
$0.019.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.34M | -3.34M | -1.95M | -2.08M | -1.14M |
| Total Depreciation and Amortization | 14.00K | 15.00K | 15.00K | 15.00K | 4.00K |
| Total Amortization of Deferred Charges | 114.00K | 164.00K | 191.00K | 142.00K | 128.00K |
| Total Other Non-Cash Items | 872.00K | 288.00K | 647.00K | 805.00K | -640.00K |
| Change in Net Operating Assets | -646.00K | 2.52M | 3.31M | 1.52M | -1.27M |
| Cash from Operations | 1.69M | -344.00K | 2.21M | 409.00K | -2.91M |
| Capital Expenditure | -2.00K | -- | 0.00 | 0.00 | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.58M | -- | 0.00 | 0.00 | 2.17M |
| Cash from Investing | 1.58M | -- | 0.00 | 0.00 | 2.17M |
| Total Debt Issued | 0.00 | 1.11M | 3.35M | 1.32M | 2.03M |
| Total Debt Repaid | -1.54M | -1.81M | -3.71M | -2.33M | -1.75M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.54M | -702.00K | -362.00K | -1.00M | 284.00K |
| Foreign Exchange rate Adjustments | 0.00 | -9.00K | -13.00K | 1.00K | 5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.74M | -1.06M | 1.83M | -592.00K | -448.00K |